Kiromic BioPharma (KRBP, $0.9) was a top loser over the last three months, falling -3 to $0.9 per share. A.I.dvisor analyzed 856 stocks in the Biotechnology Industry for the 3-month period ending December 31, 2024, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.